The Global Drug-Coated Balloons Market size was valued at US$ 600.3 million in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 16.7% from 2020 to 2028. Drug-coated balloon (DCB) is defined as a semi-compliant angioplasty balloons layered with a cytotoxic chemotherapeutic agent. At present, paclitaxel coated balloons are gaining popularity in commercial applications.  In recent years, drug-coated balloons have emerged as a stimulating technology developed to modify the limitations challenged by drug-eluting stents and is further expected to prove effective in complex subsets. Numerous drug-coated balloons identified for coronary and peripheral applications were estimated recently in preclinical and clinical studies with encouraging results.

The Market is anticipated to be driven by rising technological advancements coupled with increased demand for the minimally invasive surgery. Growing prevalence of Peripheral and coronary artery diseases across the globe is also considered as one of the major factors driving the market. Rapidly augmenting geriatric population with cardiovascular diseases, huge patient base in developing countries, and cumulative investments in R&D for treatment of peripheral and coronary artery diseases are the are other significant factors driving the market growth.

The Global Drug-Coated Balloons market is categorized on the basis of product, End user and region. On the basis of product type, the market is segmented into Drug-Coated Balloons for Peripheral Artery Disease, Drug-Coated Balloons for Coronary Artery Disease, and Drug-Coated Balloons for Other Indications. On the basis of End user, the market is segmented into Hospitals, Cardiac Catherization Labs, and Ambulatory Surgical Centers.  Based on region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among all, North America is expected to dominate the market during the analysis of forecast period.

The key players of this market include Medtronic, BD, Koninklijke Philips, B. Braun Melsungen, BIOTRONIK, Boston Scientific, Opto Circuits (India), Acotec Scientific, AR Baltic Medical, Acrostak, Biosensors International Group, Cardionovum, Concept Medical, ENDOCOR, Hexacath, iVascular SLU, M.A. Med Alliance, Minvasys, Orchestra BioMed, QT Vascular, RD Global-Invamed, Surmodics, Terumo, Wellinq, and Other prominent players.